Meet Jeffrey Rudd, our expert U.S. Head of Finance! With nearly 20 years of financial leadership, Jeffrey brings deep expertise in scaling growth and maximizing profitability. As a former CFO, he successfully led a SaaS company from seed stage to a successful exit—a testament to his strategic vision and operational excellence. Join us in welcoming Jeffrey and celebrating the leadership that will help take Acarix to the next level.
Acarix
Medicinsk utrustning
Malmö, Skane County 3 767 följare
Revolutionizing cardiac diagnostics with the CADScor®System, an AI-driven tool for rapid and non-invasive CAD detection.
Om oss
Acarix is a pioneering Swedish medical device company, with an expanding presence in the U.S., transforming cardiac diagnostics with AI-powered acoustic technology. Our flagship solution, the CADScor® System, can rapidly and non-invasively risk stratify Coronary Artery Disease, helping physicians confidently assess chest pain patients while reducing unnecessary, costly, and invasive procedures. With CE-mark approval and FDA De Novo clearance, the CADScor®System provides a patient-specific CAD-score with 96% confidence, streamlining decision-making in both primary and specialized care. Backed by innovation and clinical validation, Acarix is committed to optimizing healthcare efficiency and improving patient care. Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX) and cross-traded on the OTCQB market in the U.S. (ticker: ACIXF).
- Webbplats
-
http://www.acarix.com
Extern länk för Acarix
- Bransch
- Medicinsk utrustning
- Företagsstorlek
- 11–50 anställda
- Huvudkontor
- Malmö, Skane County
- Typ
- Publikt aktiebolag
- Grundat
- 2009
- Specialistområden
- Acoustics, Stable Chestpain, Coronary Artery Disease, CAD och Diagnostic Aid
Adresser
-
Primär
Jungmansgatan 12
Malmö, Skane County 211 11, SE
-
Ryvangs Allé 81-83
Hellerup, 2900, DK
-
251 W 30th St
5th Floor
New York, New York 10001, US
-
Universitätsstraße 71
Cologne, North Rhine-Westphalia 50931, DE
Anställda på Acarix
Uppdateringar
-
Did you know that 9 out of 10 patients referred for diagnostic procedures don't have significant CAD? This surprising statistic underscores the need for more accurate and efficient diagnostic tools. Our #CADScorSystem is here to help - accurately ruling out #CoronaryHeartDisease and ensuring that only those who truly need further testing are referred. Discover how we're transforming heart health diagnostics: #MedicalDevices #MedTech #Diagnostics
-
-
On National Doctors' Day, we honor dedicated physicians worldwide for their vital role in advancing cardiac care. A special thank you to those using the #CADScorSystem. Your expertise and commitment to early, AI-powered diagnostics make a difference in patients’ lives every day. #NationalDoctorsDay #CardiacInnovation
-
-
It’s Day 2 at #ACC25 in Chicago! We are proud to share how our #CADScorSystem is helping providers work smarter and faster. With its easy-to-use design and seamless workflow integration, the CADScor System empowers providers to deliver immediate, radiation-free risk assessments, all without relying on the cloud. If you haven’t stopped by yet, visit booth 20062 to see how we're changing the game in cardiovascular care! #ACC25 #HealthInnovation #Cardiology
-
-
#ACC25 Day 1 Is HERE! Visit Acarix at booth 20062 to see the #CADScorSystem in action. This non-invasive tool layers advanced acoustics and AI for rapid #CoronaryArteryDisease assessment, quickly identifying risk and helping you skip unnecessary evaluations. Transform your approach to cardiac care! #ACC25 #HealthInnovation #MedTech
-
-
Did you know that 1 in 20 adults aged 20 and older are affected by coronary heart disease? This alarming fact from the Centers for Disease Control and Prevention underscores the urgency of early detection. Our #CADScorSystem is essential in delivering early and accurate diagnoses. Discover how it makes a difference: https://lnkd.in/gsTw9_K5
-
-
Attending #ACC25? Visit us at booth 20062 to explore the #CADScorSystem, a non-invasive, AI-powered diagnostic tool that analyzes coronary blood flow using acoustics. It provides instant results without needing cloud analysis. Learn more: https://lnkd.in/gsTw9_K5 #Cardiology #HealthcareTech #ACC25
-
-
Meet Carma Connely, a powerhouse in the medical device field with 20+ years of expertise in neurosurgery and cardiology. From leading operations at Coala Life to launching European firms in the U.S., her diverse skills in sales, quality, and clinical education drive innovation at Acarix. Join us in celebrating Carma’s leadership in medtech! https://lnkd.in/gHeYAane
-
-
The #CADScorSystem revolutionizes point-of-care diagnostics by providing healthcare professionals with an accessible, non-invasive tool. With a confirmed NPV of 95.4%-97.2% (1,2), it enables faster, more confident decision-making, reducing unnecessary tests and easing patient anxiety. Discover the future of cardiac care today. https://lnkd.in/gsTw9_K5 1. Schmidt SE, et al. Int J Cardiovasc Imaging. https://lnkd.in/gr4YVqvA 2. Rasmussen LD, et al. Heart. https://lnkd.in/gazkcZWH
-
-
Acarix is heading to American College of Cardiology's #ACC25 conference! We can't wait to connect with peers, share insights, and showcase the latest in AI-powered cardiac diagnostics. Stop by booth 20062 to explore how the #CADScorSystem is transforming early cardiac assessments and redefining #CoronaryArteryDisease risk stratification. See you there! #ACC25 #Cardiology #HealthInnovation #MedTech
-